T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Exelon
EXC
$46.8B
| $77.1M | 0.01% |
2,227,286
+836,601
| +60% | +$30.9M |
|
602
UFP Industries
UFPI
$5.07B
| $76.5M | 0.01% |
683,250
-55,358
| -7% | -$6.43M |
|
603
Axcelis
ACLS
$4.47B
| $75.5M | 0.01% |
531,130
+67,992
| +15% | +$7.84M |
|
|
MORF
604
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $75.2M | 0.01% |
2,207,187
-316,399
| -13% | -$9.37M |
|
605
Xencor
XNCR
$1.7B
| $75M | 0.01% |
3,962,403
+142,747
| +4% | +$3.07M |
|
606
United Therapeutics
UTHR
$21.7B
| $74.8M | 0.01% |
234,916
+207,940
| +771% | +$55M |
|
607
Kraft Heinz
KHC
$29.7B
| $74.6M | 0.01% |
2,315,199
-580,956
| -20% | -$20.7M |
|
608
Factset
FDS
$9.82B
| $74.3M | 0.01% |
181,937
-22,396
| -11% | -$9.52M |
|
609
Freshpet
FRPT
$3.47B
| $73.9M | 0.01% |
571,030
+472,106
| +477% | +$56.7M |
|
610
SPS Commerce
SPSC
$2.72B
| $73.4M | 0.01% |
390,078
-18,768
| -5% | -$3.43M |
|
611
Cognex
CGNX
$10.4B
| $73.1M | 0.01% |
1,563,761
-55,246
| -3% | -$2.43M |
|
612
Seagate
STX
$208B
| $72.2M | 0.01% |
699,198
+441,165
| +171% | +$41.2M |
|
613
Blue Owl Capital
OWL
$19B
| $71.8M | 0.01% |
4,044,434
+942,840
| +30% | +$17.3M |
|
614
Procept Biorobotics
PRCT
$1.25B
| $71.4M | 0.01% |
1,169,302
-298,357
| -20% | -$17.7M |
|
615
Royal Gold
RGLD
$19.2B
| $70.6M | 0.01% |
563,960
-45,800
| -8% | -$5.72M |
|
616
Casey's General Stores
CASY
$31.5B
| $70.1M | 0.01% |
183,588
+9,167
| +5% | +$3.06M |
|
617
Arcos Dorados Holdings
ARCO
$1.73B
| $69.5M | 0.01% |
7,726,732
+5,112,007
| +196% | +$52.6M |
|
618
Digital Realty Trust
DLR
$73.2B
| $68.9M | 0.01% |
453,334
+39,417
| +10% | +$5.66M |
|
619
Ford
F
$55.4B
| $68.9M | 0.01% |
5,496,235
+146,959
| +3% | +$1.82M |
|
620
Lamar Advertising Co
LAMR
$15.9B
| $68.7M | 0.01% |
575,120
+8,476
| +1% | +$986K |
|
621
Rocket Pharmaceuticals
RCKT
$370M
| $68.2M | 0.01% |
3,169,448
+226,288
| +8% | +$5.2M |
|
622
Scholar Rock
SRRK
$6.68B
| $68.2M | 0.01% |
8,188,127
-19,986
| -0.2% | -$244K |
|
623
Halozyme
HALO
$11.4B
| $68.2M | 0.01% |
1,301,687
+2,843
| +0.2% | +$125K |
|
|
LBPH
624
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $67.8M | 0.01% |
2,508,536
+290,541
| +13% | +$5.73M |
|
625
Matador Resources
MTDR
$6.39B
| $67.7M | 0.01% |
1,136,088
+31,297
| +3% | +$1.97M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.